Catalyst Wire Dossier Catalyst Wire Dossier

Tiragolumab

tiragolumab · Genentech
Drug timelines are a Plus or Pro feature.

45 regulatory and trial events tracked for Tiragolumab, covering 2020-07-09 to 2026-06-18. Get the full timeline:

Most recent: Clinical Trial Results: A Study to Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid Tumors [Phase 2]

See pricing